Main page content begins

Linklaters advises on acquisition of Syngenta AG by ChemChina 

12 June 2017

  • ChemChina's US$43bn acquisition of Syngenta is the largest overseas takeover by a Chinese company in history
  • Linklaters advised lenders on the US$20bn bridge facilities for the acquisition

Linklaters advised HSBC Bank plc on the US$20bn loan facilities for the acquisition of Syngenta AG, the Swiss seed and pesticide maker, by China National Chemical Corporation (ChemChina), the Chinese state-owned chemical company.
The Chinese group’s buyout of the seed maker is set to turn the company into an agrichemical powerhouse. Following the receipt of a number of regulatory approvals, final settlement of the tender offers took place on 7 June 2017, with ChemChina acquiring a 94.7 per cent stake in Syngenta making the deal China’s largest ever cross-border acquisition.

The financing of the acquisition consisted of US$15bn term bridge facilities as well as US$5bn backstop facilities made available for the purposes of refinancing existing debt in Syngenta.   
The Linklaters team was led by Brian Gray (Banking Partner) and Ian Callaghan (Banking Partner).



Search our news archive

Choose one or more criteria to narrow your search